The Relationship Between Microsatellite Instability and Efficacy of Fluorouracil Based Adjuvant Chemotherapy in Gastric Cancer After Operation
NCT03485196 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2022-08-10
Summary
The relationship between Microsatellite instability and efficacy of fluorouracil based adjuvant chemotherapy in gastric cancer after operation.
Conditions
Interventions
- OTHER
-
Microsatellite instability
The microsatellite instability status are definite to three type:MSI-H, MSI-L,and MSS. The gastric cancer patients who received D2 resection were included in 3 groups:MSI-H group, MSI-L group,and MSS group. All patient must be accept fluorouracil(5-FU) based adjuvant chemotherapy. We will analyze the relationship between MSI status and efficacy of 5-FU based adjuvant chemotherapy by observing the survival period of patients with different MSI status.
Sponsors & Collaborators
-
Qinghai People's Hospital
collaborator OTHER -
LanZhou University
collaborator OTHER -
Affiliated Hospital of Qinghai University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-01
- Primary Completion
- 2021-04-01
- Completion
- 2021-04-01
Countries
- China
Study Locations
More Related Trials
-
Postoperative Chemoradiotherapy With S-1 in Gastric Cancer
NCT01824004 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Efficacy of PD-1 Monoantrapical Chemotherapy in the Treatment of Local Advanced Stomach Cancer
NCT05000554 ·Status: RECRUITING ·Phase: PHASE2
-
Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor
NCT03399253 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma
NCT02301481 ·Status: COMPLETED ·Phase: PHASE2
-
Compare Different Response Evaluations to Neoadjuvant Chemotherapy for Gastric Cancer
NCT02179463 ·Status: UNKNOWN
-
Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer
NCT05140746 ·Status: RECRUITING ·Phase: NA
-
Laparoscopic D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers
NCT03468712 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Long-term Outcomes Between Upfront Surgery and Neoadjuvant Therapy Followed by Surgery in Patients with Node-Negative Gastric Cancer
NCT06673472 ·Status: COMPLETED
-
Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer
NCT00420394 ·Status: UNKNOWN ·Phase: PHASE2
-
the Optimal Surveillance Frequency for Stage II/III Gastric Cancer
NCT05465993 ·Status: COMPLETED
-
Real World Evidence for the Cycle of Neoadjuvant Chemotherapy in Gastric Cancer With Shared Decision Making
NCT03413514 ·Status: UNKNOWN ·Phase: NA
-
Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study
NCT03978481 ·Status: COMPLETED
-
The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer
NCT06235164 ·Status: ACTIVE_NOT_RECRUITING
-
Nutrition-support-team Based Intervention in Patients With Advanced Gastrointestinal Cancer
NCT03631537 ·Status: UNKNOWN ·Phase: NA
-
First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
NCT06727981 ·Status: RECRUITING
-
Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer
NCT06157216 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer
NCT00587145 ·Status: UNKNOWN ·Phase: PHASE2
-
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
NCT01053390 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Faecal Bacteria Detection in Early Screening and Diagnosis of GC
NCT04638959 ·Status: UNKNOWN
-
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension
NCT04882241 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
NCT03425058 ·Status: COMPLETED
-
Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric Cancer
NCT04850716 ·Status: UNKNOWN
-
Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers
NCT03515941 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients
NCT03874871 ·Status: UNKNOWN
-
PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery
NCT05468138 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2